Bottom line
RYILX vs RYSBX: the short answer
RYILX (Inverse High Yield Strategy Fund) and RYSBX (Strengthening Dollar 2x Strategy Fund) are both mutual funds.
RYILX is cheaper at 1.64% vs 1.93% — a difference of $29 a year per $10,000 invested.
Over five years, RYSBX returned +6.4% a year vs −1.8% for RYILX.
RYILX has a front-end sales load of up to 4.75%; the other does not.
Updated Nov 19, 2026
RYILX vs RYSBX side by side
| RYILX | RYSBX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Guggenheim | Guggenheim |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 1.64% | 1.93% |
| Annual cost per $10k | $164 | $193 |
| 10-yr cost on $10k (prospectus) | $2,402 | $2,351 |
| Max front load | 4.75% | — |
| 12b-1 fee | 0.25% | 0.25% |
| 1-yr return | −8.9% | −14.1% |
| 5-yr return (annualized) | −1.8% | +6.4% |
| 10-yr return (annualized) | −4.3% | +1.9% |
| Best quarter | — | +17.3% |
| Worst quarter | — | −14.4% |
| Net assets (fund) | $827.7K | $2.3M |
| Number of holdings | 7 | 4 |
| Portfolio turnover | % | % |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
2 of RYILX's top 7 holdings also appear in RYSBX's top 4.
| Holding | RYILX | RYSBX |
|---|---|---|
| J.p. Morgan Securities Llc | 35.79% | 46.73% |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | 35.79% | 46.73% |
Source: SEC Form N-PORT
RYILX top 10
- J.p. Morgan Securities Llc — 35.79%
- Merrill Lynch, Pierce, Fenner & Smith Incorporated — 35.79%
- Guggenheim Funds Trust — 20.32%
- Guggenheim Funds Trust — 4.48%
- Board Of Trade Of The City Of Chicago, Inc. — -0.29%
- Intercontinental Exchange, Inc. — -0.49%
- Intercontinental Exchange, Inc. — -7.36%
RYSBX top 10
- J.p. Morgan Securities Llc — 46.73%
- Merrill Lynch, Pierce, Fenner & Smith Incorporated — 46.73%
- Ice Futures U.s. — 0.89%
- Goldman Sachs & Co. Llc — 0.36%
FAQ
What is the difference between RYILX and RYSBX?
Which is cheaper, RYILX or RYSBX?
Should I own both RYILX and RYSBX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.